AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 99 filers reported holding AKERO THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $78,000 | +95.0% | 2,305 | -45.3% | 0.01% | -50.0% |
| Q2 2022 | $40,000 | -33.3% | 4,212 | 0.0% | 0.01% | -9.1% |
| Q1 2022 | $60,000 | -32.6% | 4,212 | 0.0% | 0.01% | -26.7% |
| Q4 2021 | $89,000 | -11.0% | 4,212 | -6.0% | 0.02% | -16.7% |
| Q3 2021 | $100,000 | -9.9% | 4,482 | 0.0% | 0.02% | +5.9% |
| Q2 2021 | $111,000 | -14.6% | 4,482 | 0.0% | 0.02% | -22.7% |
| Q1 2021 | $130,000 | +12.1% | 4,482 | 0.0% | 0.02% | +10.0% |
| Q4 2020 | $116,000 | -15.9% | 4,482 | 0.0% | 0.02% | -23.1% |
| Q3 2020 | $138,000 | +97.1% | 4,482 | +60.2% | 0.03% | +100.0% |
| Q2 2020 | $70,000 | – | 2,798 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| University of Wisconsin Foundation | 423,849 | $9,943,498 | 11.19% |
| Propel Bio Management, LLC | 327,752 | $7,689,062 | 4.99% |
| GENERAL ATLANTIC, L.P. | 5,233,989 | $122,789,382 | 3.86% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 625,087 | $14,664,541 | 3.46% |
| Yiheng Capital Management, L.P. | 1,434,179 | $33,645,839 | 2.71% |
| Redmile Group, LLC | 1,614,473 | $37,875,537 | 2.29% |
| Boxer Capital, LLC | 1,676,733 | $39,336,156 | 2.07% |
| RTW INVESTMENTS, LP | 5,431,985 | $127,434,368 | 1.97% |
| Logos Global Management LP | 800,000 | $18,768,000 | 1.52% |
| MPM BioImpact LLC | 385,990 | $9,055,325 | 1.41% |